ICH Q6A/Q6B tests for cytokine-antibody fusions
Biosimilar Development: Science, Strategy, and Standards Behind Affordable Biologics As the global demand for cost-effective biologic therapies continues to rise, biosimilars have become a cornerstone in modern drug development. These are not generic drugs—they are highly similar, scientifically engineered alternatives to complex biologic medicines, and their development requires a blend of rigorous analytics, clinical science, […]